Children undergoing a pioneering new treatment at the Seattle Children’s Research Institute have an extra ally in their corner, a little bear wearing a purple cloak and mask who goes by the name of “T-Bear.”
Study finds that research in pediatric lymphoma is still lacking. Read more here.
The Therapeutic Cell Production Core (TCPC) are using the teddy bear alongside their new T-cell treatment for children who have relapsed acute lymphoblastic leukemia (ALL). The treatment involves retrieving T-cells from the young patients and then “re-engineering” the cells so that they can recognize the cancer cells. These T-cells are then returned to the patient where they seek out the cancer cells to destroy them. So far, this treatment has a 93 percent success rate for complete remission.
When the children undergo the treatment they are given a “T-Bear” to comfort them during the sessions and provide a personal touch that families really appreciate. Find out more about the great work of the TCPC in this medical xpress article.
Read how children with pediatric Hodgkin’s lymphoma may be at risk of relapse if they gain body fat.
Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
